Matricel develops and manufactures innovative medical devices and pharmaceutical excipients for applications in medicine and biotechnology. The main product focus are medical class III collagen implants for clinical applications in regenerative medicine.

10 000 clinical applications in tissue engineering

Matricel 's product ACI-Maix is one of the first products in Europe and Australia, which was used for tissue engineering of articular cartilage in the knee. More than 10.000 patients have been treated successfully with this collagen matrix as part of the so-called "collagen-covered autologous chondrocyte implantation (CACI) and the "matrix-induced autologous chondrocyte implantation (MACI ®). Further information regarding this innovative treatment can be found on the dedicated MACI-Website provided by Genzyme Corporation. more

International certifications

The quality management system of Matricel is certified according to DIN EN ISO 13485:2010 and according to the Therapeutic Goods (Medical Device) Regulations 2002 (Australia) for development, manufacture and marketing of biomaterials for medical, pharmaceutical and biotechnology applications.